Biowaiver for lower strength [Study Per­for­mance]

posted by luvblooms  – India, 2021-08-18 12:34 (1386 d 01:10 ago) – Posting: # 22527
Views: 3,539

Hi Vishal

❝ clarification-after in vitro testing, the 2.5mg strength does not show proportional similarity and acceptable in vitro dissolution testing.


A common problem with drugs that have dose-dependent solubility.
The best way to handle this scenario is to go with does equivalent dissolution approach (assuming your formulation is dose-proportional).

Example:

2.5 mg *8 vs 20 mg
5 mg*4 vs 20
10mg *2 vs 20

There are few SBoA's available where FDA has recommended this approach.
I am trying to find those and will update the post if I am able to get those.

~A happy Soul~

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,680 registered users;
44 visitors (0 registered, 44 guests [including 15 identified bots]).
Forum time: 13:44 CEST (Europe/Vienna)

Pharmacokinetics: one of the magic arts of divination
whereby needles are stuck into dummies in an attempt
to predict profits.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5